Shanghai Dongfulong Biological Reagents Co., Ltd.
Basic information
- Head office
- Chief executive
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2021-01-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| 上海东富龙医疗科技产业发展有限公司 | ||||||||
|
Dongfu Long Technology Group Co., Ltd.
|
Network
History
Establishment of Shanghai Dongfulong Medical Technology Industry Development Co., Ltd.; Development of systematic solutions for large-molecule drugs and cell therapy.![]()
Acquisition of a CAR-T company focused on cell drug process R&D; establishment of a biological cell laboratory and research on cell culture technology; creation of a GMP demonstration center for cell drug conversion public service platform; establishment of a dedicated department for medium R&D and production under the life science division; construction of a medium R&D and pilot production laboratory for formulation research.![]()
Founded in 2021, Dongfulong Biological Reagents is a wholly-owned subsidiary of Dongfulong Technology Group Co., Ltd. It focuses on life science research and biotechnology industry, aiming to build an integrated domestic bioreagent R&D, application transformation, and industrial production and sales platform, providing comprehensive support for key reagents and overall domestic solutions.![]()
ISO9001:2015 quality system certification obtained in December 2021; launched systematic commercial medium products for large-molecule drugs and cell therapy; achieved international and domestic market launch and promotion of proprietary medium products.![]()
Technical breakthrough: Development and production of CHO, HEK293 series product formulations. Production capacity breakthrough: Establishment of a scaled-up production line (Hangzhou Medical Town). Performance breakthrough: Achieved international supply chain for domestically produced culture media. Certification documents: DMF registration filing (CHO, HEK293).![]()
News
There is no news.